
寶碩跨足綠能產業傳弊端,涉嫌透過孫公司昶陽能源以不實合約虛增營收,部分款項疑流入前總經理帳戶,北檢指揮搜索並約談10人。
上櫃公司寶碩財務科技涉嫌透過孫公司昶陽能源,以不實合約將完工太陽能電廠工程發包給母公司,虛增5000萬元營業額,部分款項疑流入前林姓總經理帳戶。台北檢調今指揮搜索10處並約談10人到案。
AI-generated summary
寶碩原以金融資訊研發為主,2022年轉型跨足綠能工程領域。
台北地檢署。(資料照)
上櫃公司寶碩財務科技跨足綠能產業,卻涉嫌透過孫公司昶陽能源,將已完工的太陽能電廠工程以不實合約發包給寶碩,虛增約5000萬元營業額,再轉包給旗下子公司,部分款項疑流入前林姓總經理帳戶。台北地檢署今指揮搜索10處,約談林及前游姓副總經理等10人,全案朝違反證券交易法特別背信等罪嫌偵辦。
檢調調查,昶陽能源在台南關廟、屏東竹田開發太陽能電廠,涉嫌於2021年7月間,將已完工的電廠相關工程,透過不實合約發包給母公司寶碩,藉此虛增寶碩約5000萬元營業額。
寶碩取得工程後,再轉包給旗下成欣、妍安兩家子公司,分別支付2800萬元及1800萬元。檢調追查,相關款項經子公司、孫公司陸續轉手,部分疑流入寶碩前林姓總經理帳戶,懷疑涉及掏空公司資產。
北檢今指揮調查局新北市調查處,兵分10路搜索寶碩旗下子公司位於台南的營業處所,以及前總經理、前副總經理等人住居所,並約談林、游等10人到案,釐清合約簽訂經過及款項流向。
寶碩原以金融資訊、財務工程研發為主,經營應用系統軟體設計開發及系統整合服務,曾開發認購權證發行管理系統、供學校教學研究使用的虛擬交易所,2022年8月正式轉型跨足太陽能光電、智慧儲能等綠能工程領域。
AI outlook — possibilities, not facts
檢調將持續釐清合約簽訂經過及款項流向
Very likely · Within weeks

As a new "Trillion City", Wenzhou, Zhejiang will continue to make efforts in 2025, through measures such as building a large-scale international consolidation base, innovating the exhibition economic model, and creating a cross-border communication platform, to empower private enterprises to go overseas from the three aspects of logistics, exhibitions, and compliance.

National Data Group Co., Ltd. was officially established in Xiongan today. Experts pointed out that the group will assume the important task of developing, integrating and operating national data resources, promote the construction of a national integrated data market, and enhance my country's position in global data resource competition.

The All-in-One Card Company announced that it has joined the Ministry of Environment’s “Environmental Protection Points” program. From October 20 to December 31, people who exchange environmental green points for All-in-One Card Green Points can enjoy a 50% off limited-time discount and receive a 50-yuan iPASS MONEY coupon to assist the goal of net-zero carbon reduction.

China's State Administration of Foreign Exchange released data on the 20th. In September 2026, banks settled US$294.2 billion in foreign exchange and sold US$238 billion in foreign exchange, with a surplus of US$56.2 billion, a month-on-month increase of 17%. Li Bin, deputy director of the State Administration of Foreign Exchange, said that China's foreign exchange market is operating generally soundly.

Taihe Biotechnology (6467) was officially listed on the 20th at 105.6 yuan per share. The company focuses on the development of new 505(b)(2) new dosage forms and new drugs. Its main product, BEQIA anti-thrombotic orally dissolving film, has been submitted to the US FDA for review and aims to obtain drug certification in April 2027.

Thanks to the booming demand for AI and high-efficiency computing, export orders in the first three quarters of this year reached US$819.2 billion, exceeding the total last year. The Census and Statistics Department pointed out that with the strong support of the AI hardware and semiconductor supply chain, there is a high chance that the annual order volume will exceed US$1.1 trillion.